Oligonucleotide Therapeutics Market: Increased Research and Development Activities in the Field to Shoot Up Demand
Global Oligonucleotide Therapeutics Market: Overview
Oligonucleotides refer to short chain DNA or RNA that are generally made by using automated synthesizers. In addition, purification of oligonucleotide is accomplished by anion exchange chromatography and it is followed by the techniques of freezing and desalting. In addition, synthesis of siRNA duplex oligonucleotide is done through an annealing step in which two purified strands of oligonucleotide are brought closer together in an equimolar ratio. There exists much difference between oligonucleotide therapeutics and conventional medicine. The oligonucleotide therapeutics are capable of holding back the expression of specific genes. This factor results in the development of brand new oligonucleotides targeting certain genes and treating chronic diseases. Chemically modified artificial nucleic acids are utilized so as to develop these new oligonucleotide therapeutics. The developed artificial oligonucleotides come with better enhanced affinity and in-vivo stability to target mRNA. These factors are likely to act as growth factors for the global oligonucleotide therapeutics market.
Technology, application, and region are the three important parameters based on which the global oligonucleotide therapeutics market has been classified.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79608
Global Oligonucleotide Therapeutics Market: Notable Developments
The global oligonucleotide therapeutics market is marked with presence of quite a few prominent players, thereby making it a fairly competitive market for both the existing players and new entrants. These companies are forging, partnerships, collaborations, and mergers in an effort to gain larger revenue and market share. The following development is expected to play an important role in the market:
- In Dec 2016, US-based Biogen LLC obtained nod from US Food and Drug Administration (FDA) for nusinersen’s new drug application. This new application involves use of Spinraza (nusinersen) injection for the purpose of treating spinal muscular atrophy in adult and pediatric patients. In this process, a first of its kind antisense oligonucleotides molecule is used for treating spinal muscular atrophy.
Some of the prominent organizations in the global oligonucleotide therapeutics market comprise the below-mentioned:
- miRagen Therapeutics, Inc.
- Ionis Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Gilead Sciences, Inc.
- Biogen Inc.
- Regulus Therapeutics Inc.
Request for Analysis of COVID-19 Impact on Oligonucleotide Therapeutics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79608
Global Oligonucleotide Therapeutics Market: Key Trends
The global oligonucleotide therapeutics market is characterized by the presence of the following restraints, drivers, and opportunities.
Increased Research and Development Activities in the Field to Shoot Up Demand
The growth of the global oligonucleotide therapeutics market is likely to be driven by several factors. The demand for oligonucleotide therapeutics is likely to rise due to the presence of very few approved molecules. This factor offers a plethora of opportunities to the players in the global oligonucleotide therapeutics market for the development of new molecular entities. In addition, the technological upgradation and advancement of chemically synthesized oligonucleotides have resulted in the coming up of more extended and stable half-life molecules. There exists nearly 135 oligonucleotide therapeutics that are in various phases of development of drugs. This new products are likely to make addition to the already existing approved therapeutics that are available in the market today.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79608
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
Pre book Oligonucleotide Therapeutics Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=79608<ype=S
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453